Clinical trial
Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure
NCT07781462 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure
- Lead sponsor
- Alexandria University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure (ahf), delirium in intensive care unit